The court of appeals affirmed a judgment. The court held that a dominant manufacturer did not violate antitrust laws by developing an innovative new technology that was incompatible with previously manufactured products.

Tyco Health Care Group, LP manufactured pulse oximetry sensors and monitors. The sensors, when attached to a subject’s wrist, transmitted data to the monitors, which, in turn, displayed the subject’s level of blood oxygenation.